High Throughput Screening

Provided by EU-OPENSCREEN

EU Openscreen

Services provided by EU-OPENSCREEN include
• high-throughput compound/ drug screening (HTS): HTS of an assay against the EU-OPENSCREEN chemical collection (> 100,000 compounds); in silico profiling; hit selection; confirmatory screening; basic
counter screening; basic SAR based on screening data; QC of confirmed hits
• access to a unique European compound collection: EU-OPENSCREEN chemical collection (> 100,000 compounds)

Visit website

Bioprofiling assays

Provided by EU-OPENSCREEN

EU Openscreen

Services provided by EU-OPENSCREEN include
• assay adaption: This assay adaptation process will involve a strong emphasis on quality, including: quality control of reagents; (patho-)physiological relevance; pharmacological consistency; robustness; minimised variability; and tracking of statistical descriptors (e.g. signal to background and the Z’ factor)
• chemical optimization and profiling of preliminary ‘hits’
• bioprofiling of donated compounds: All compounds donated by the user which enter the EU-OPENSCREEN ERIC compound collection are characterised and annotated for basic physico-chemical (e.g. identity, solubility, light absorbance and fluorescence) and essential to know biological properties (cytotoxicity, antibiotic, antifungal etc.) by testing in a standard panel of assays.
• provision of standardised data: All data generated through QC/bioprofiling and screening activities will be published in EU-OPENSCREEN’s open-access database with an optional ‘grace’ period (i.e. delayed publication of data). Large-scale open-access data provide the basis for computational data integration to obtain a systematic view, allow for prediction of drug-target interactions and networks as well as of adverse effects and drug combinations. The access to the EU-OPENSCREEN database will utilize the facilities of ChEMBL.

Visit website

Training on HTS and informatics

Provided by EU-OPENSCREEN

EU Openscreen

EU-OPENSCREEN provides training and education activities in the aread of assay development, assay technologies, instrumentation and automation, compound management, and informatics.

Visit website